We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Mepolizumab (rch)
Australian Public Assessment Report
Device/Product Name
Nucala
Active ingredients
Mepolizumab (rch)
AusPAR Date
Published
Submission Number
PM-2014-03872-1-5
Submission Type
New biological entity
Decision
Approved